Laman UtamaOCEAW • NASDAQ
add
Ocean Biomedical
Tutup sebelumnya
$0.033
Julat hari
$0.026 - $0.034
Julat tahun
$0.020 - $0.70
Permodalan pasaran
21.77J USD
Bilangan Purata
57.48K
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Jun 2024info | Perubahan T/T |
|---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 682.00K | -75.92% |
Pendapatan bersih | -17.23J | -50.77% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | — | — |
EBITDA | — | — |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 4.00K | -99.66% |
Jumlah aset | 1.85J | -14.35% |
Jumlah liabiliti | 94.59J | 48.22% |
Jumlah ekuiti | -92.74J | — |
Syer tertunggak | 34.87J | — |
Harga kepada buku | -0.01 | — |
Pulangan pada aset | -71.09% | — |
Pulangan pada modal | 2.48% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -17.23J | -50.77% |
Tunai daripada operasi | -290.00K | 93.94% |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | -290.00K | -115.63% |
Aliran tunai bebas | -1.46J | -70.74% |
Perihal
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Diasaskan
2019
Ibu pejabat
Tapak web
Pekerja
7
